LENSAR Inc (LNSR) Stock Analysis

LENSAR Inc (LNSR) is a publicly traded company in the HEALTHCARE sector. It trades at $5.74, carries a market capitalization of $70.20M. This page summarizes the public market data, fundamentals, and frequently asked questions for LNSR, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

Market Sentiment

LENSAR Inc currently has a Neutral sentiment score of 0.12.

About LENSAR Inc

LENSAR, Inc. is a commercial-stage medical device company based in Orlando, Florida, that specializes in cutting-edge solutions for ophthalmic surgery, particularly with its flagship femtosecond laser system designed for cataract procedures and corneal astigmatism management. As a pioneer in laser-assisted cataract surgery, LENSAR is positioned to capitalize on the growing demand for innovative ophthalmic technologies, thereby enhancing surgical outcomes and expediting patient recovery. The c...

GNG Research Analysis

GNG Research scores LENSAR Inc (LNSR) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for LNSR.

Frequently Asked Questions

Does LNSR pay dividends?

LENSAR Inc (LNSR) does not currently pay a regular dividend.

What is LNSR's market cap?

LENSAR Inc (LNSR) has a market capitalization of $70.20M with a current stock price of $5.74.